Publications by authors named "Eugene McFadden"

Claim this Profile
P
Personalized or Standard Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: The PARTHENOPE Randomized Trial.
Raffaele Piccolo, Paolo Calabrò, Greta Carrara, Fiorenzo Simonetti, Attilio Varricchio, Eugene McFadden

J Am Coll Cardiol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immediate versus staged complete revascularization in patients presenting with multivessel disease and ST- or non-ST-segment elevation acute coronary syndrome.
Jacob J Elscot, Hala Kakar, Wijnand K den Dekker, Johan Bennett, Manel Sabaté, Eugene McFadden

Int J Cardiol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipid-lowering therapy treatment regimens in high- and very high-risk patients for the prevention of cardiovascular events: results from the Irish cohort of the multinational, observational SANTORINI study.
Himanshu Rai, John Joseph Coughlan, Daniel O'Callaghan, Richard Sheahan, Ross Murphy, Eugene McFadden

Ir J Med Sci· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Underrepresented patient populations in cardiovascular device trials: A transatlantic expert narrative on sex, age, demographic groups, and geographical background.
Ernest Spitzer, Francesco Costa, Ingibjörg Jóna Guðmundsdóttir, José M de la Torre Hernández, Luca Testa, Eugene McFadden

Int J Cardiol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial intelligence-assisted left ventricular global longitudinal strain assessment in patients with acute myocardial infarction: a RESUS-AMI trial sub-analysis.
Demeke Mekonnen, Ernest Spitzer, Eugene P McFadden, Noel M Caplice, Claire B Ren

Int J Cardiovasc Imaging· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polymer-free versus biodegradable-polymer drug-eluting stent in patients undergoing percutaneous coronary intervention: an assessor-blind, non-inferiority, randomised controlled trial.
Raffaele Piccolo, Paolo Calabrò, Greta Carrara, Attilio Varricchio, Cesare Baldi, Eugene McFadden

EuroIntervention· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
De-escalation to ticagrelor monotherapy versus 12 months of dual antiplatelet therapy in patients with and without acute coronary syndromes: a systematic review and individual patient-level meta-analysis of randomised trials.
Marco Valgimigli, Sung-Jin Hong, Felice Gragnano, Konstantina Chalkou, Anna Franzone, Eùgene P McFadden

Lancet· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Ticagrelor or Clopidogrel Monotherapy vs Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: A Systematic Review and Patient-Level Meta-Analysis.
Marco Valgimigli, Felice Gragnano, Mattia Branca, Anna Franzone, Bruno R da Costa, Eùgene P McFadden

JAMA Cardiol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Use of cardiovascular registries in regulatory pathways: perspectives from the EU-MDR Cardiovascular Collaboratory].
Ernest Spitzer, José M de la Torre Hernández, Ingibjörg Jóna Guðmundsdóttir, Eugene McFadden, Claes Held

REC Interv Cardiol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravascular ultrasound-guided versus angiography-guided percutaneous coronary intervention in unprotected left main coronary artery disease: A systematic review.
Blaz Mrevlje, Eugene McFadden, Jose M de la Torre Hernández, Luca Testa, Giovanni Luigi De Maria

Cardiovasc Revasc Med· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rationale and design of the PARTHENOPE trial: A two-by-two factorial comparison of polymer-free vs biodegradable-polymer drug-eluting stents and personalized vs standard duration of dual antiplatelet therapy in all-comers undergoing PCI.
Raffaele Piccolo, Paolo Calabrò, Attilio Varricchio, Cesare Baldi, Giovanni Napolitano, Eugene McFadden

Am Heart J· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
P2Y Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events.
Felice Gragnano, Davide Cao, Leah Pirondini, Anna Franzone, Hyo-Soo Kim, Eugene P McFadden

J Am Coll Cardiol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Target Vessel SYNTAX Score: A Simple Additional Predictor of Renal Risk in Patients Undergoing Rotational Atherectomy?
Eugène P McFadden, Avinash Radhakrishna

Cardiovasc Revasc Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
P2Y Inhibitor Monotherapy or Dual Antiplatelet Therapy After Complex Percutaneous Coronary Interventions.
Felice Gragnano, Roxana Mehran, Mattia Branca, Anna Franzone, Usman Baber, Eùgene P McFadden

J Am Coll Cardiol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Independence of clinical events committees: A consensus statement from clinical research organizations.
Ernest Spitzer, Alexander C Fanaroff, C Michael Gibson, Jonathan Seltzer, Eugene McFadden

Am Heart J· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Ticagrelor Monotherapy or Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation: Per-Protocol Analysis of the GLOBAL LEADERS Trial.
Felice Gragnano, Marcel Zwahlen, Pascal Vranckx, Dik Heg, Kurt Schmidlin, Eugene P McFadden

J Am Heart Assoc· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Importance of Using the Appropriate Model for Systematic Reviews and Meta-analyses.
Jorge Sanz-Sánchez, Eugene McFadden, Hector M Garcia-Garcia

JAMA Intern Med· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prosthetic valve endocarditis after transcatheter aortic valve replacement in low-risk patients.
Giorgio A Medranda, Toby Rogers, Syed W Ali, Cheng Zhang, Corey Shea, Eugene P McFadden

Catheter Cardiovasc Interv· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PRECISE-DAPT score for bleeding risk prediction in patients on dual or single antiplatelet regimens: insights from the GLOBAL LEADERS and GLASSY.
Felice Gragnano, Dik Heg, Anna Franzone, Eugène P McFadden, Sergio Leonardi

Eur Heart J Cardiovasc Pharmacother· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials.
Marco Valgimigli, Felice Gragnano, Mattia Branca, Anna Franzone, Usman Baber, Eùgene P McFadden

BMJ· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Investigator-Reported and Clinical Event Committee-Adjudicated Outcome Events in GLASSY.
Sergio Leonardi, Mattia Branca, Anna Franzone, Eugene McFadden, Raffaele Piccolo

Circ Cardiovasc Qual Outcomes· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI: An Individual Patient-Level Meta-Analysis.
Marco Valgimigli, Roxana Mehran, Anna Franzone, Bruno R da Costa, Usman Baber, Eùgene P McFadden

JACC Cardiovasc Interv· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Ticagrelor alone or conventional dual antiplatelet therapy in patients with stable or acute coronary syndromes.
Anna Franzone, Eugène P McFadden, Sergio Leonardi, Raffaele Piccolo, Pascal Vranckx

EuroIntervention· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Periprocedural Myocardial Injury: Pathophysiology, Prognosis, and Prevention.
Mohamad Soud, Gavin Ho, Alexandre Hideo-Kajita, Omar Yacob, Ron Waksman, Eugène P McFadden

Cardiovasc Revasc Med· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular Clinical Trials in a Pandemic: Immediate Implications of Coronavirus Disease 2019.
Ernest Spitzer, Ben Ren, Jasper J Brugts, Joost Daemen, Eugene McFadden

Card Fail Rev· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis